Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.

导出 LinkOut

翻译打印收藏纠错

作者： Haiyan,Li ^[1] ; Weijiang,Zhang ^[2] ; Claire,Petry ^[3] ; Lindong,Li ^[4] ; Elena,Fernandez ^[3] ; Anna,Kiialainen ^[3] ; Sheng,Feng ^[5] ; Wanling,Hsu ^[4] ; Li,Li ^[4] ; Yudong,Wei ^[6] ; Christophe,Schmitt ^[3]

作者单位： Drug Clinical Trial Center and the Department of Cardiology, Peking University, Third Hospital, Beijing, China. ^[1] F. Hoffmann-La Roche Ltd., New York, New York, USA. ^[2] F. Hoffmann-La Roche AG, Basel, Switzerland. ^[3] F. Hoffmann-La Roche Ltd, Roche Product Development Shanghai, Shanghai, China. ^[4] F. Hoffmann-La Roche Ltd, pRED Roche Shanghai, China. ^[5] Drug Clinical Trial Center, Peking University, Third Hospital, Beijing, China. ^[6]

关键词 Chinese emicizumab healthy subjects pharmacodynamics pharmacokinetics

主题词成年人(Adult);抗体(Antibodies);抗体, 双特异性(Antibodies, Bispecific);因子Ⅷ(Factor VIII);人类(Humans);注射, 皮下(Injections, Subcutaneous);男(雄)性(Male);青年人(Young Adult)

DOI 10.1002/cpdd.805

PMID 32433829

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacology in drug development

2021年10卷1期

30-38页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

检索历史清除